zoletil 100 süstelahuse pulber ja lahusti
virbac - tiletamiin+zolasepaam - süstelahuse pulber ja lahusti - 50mg+50mg 1ml 5ml 1tk
cefzil suukaudse suspensiooni pulber
bausch health ireland limited - tsefprosiil - suukaudse suspensiooni pulber - 50mg 1ml 60ml 1tk; 50mg 1ml 100ml 1tk
zoletil 50 süstelahuse pulber ja lahusti
virbac - tiletamiin+zolasepaam - süstelahuse pulber ja lahusti - 25mg+25mg 1ml 5ml 1tk
falakef suukaudse suspensiooni pulber
nextmune italy s.r.l. - tsefaleksiin - suukaudse suspensiooni pulber - 50mg 1ml 100ml 1tk; 50mg 1ml 60ml 1tk
sivextro
merck sharp & dohme b.v. - tedisolidfosfaat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
xydalba
abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibacterials süsteemseks kasutamiseks, - Ägeda bakteriaalse naha ja naha struktuuri nakkuste (absssi) ravi täiskasvanutel.
tenkasi (previously orbactiv)
menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibacterials süsteemseks kasutamiseks, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4. 2, 4. 4 ja 5. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials süsteemseks kasutamiseks, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
marbocyl p tablett
vetoquinol s.a. - marbofloksatsiin - tablett - 5mg 50tk; 5mg 30tk; 5mg 20tk; 5mg 100tk; 5mg 40tk; 5mg 10tk; 5mg 250tk
daptomycin norameda süste-/infusioonilahuse pulber
norameda uab - daptomütsiin - süste-/infusioonilahuse pulber - 350mg 1tk; 350mg 5tk